journal article·2011-08-23

Magnetic Nanoparticle-Mediated Gene Transfer to Oligodendrocyte Precursor Cell Transplant Populations Is Enhanced by Magnetofection Strategies

Stuart I. Jenkins, Mark R. Pickard, Nicolas Granger, Divya M. Chari

ACS Nano· Volume 5· Issue 8
Publisher page

Abstract

This study has tested the feasibility of using physical delivery methods, employing static and oscillating field "magnetofection" techniques, to enhance magnetic nanoparticle-mediated gene transfer to rat oligodendrocyte precursor cells derived for transplantation therapies. These cells are a major transplant population to mediate repair of damage as occurs in spinal cord injury and neurological diseases such as multiple sclerosis. We show for the first time that magnetic nanoparticles mediate effective transfer of reporter and therapeutic genes to oligodendrocyte precursors; transfection efficacy was significantly enhanced by applied static or oscillating magnetic fields, the latter using an oscillating array employing high-gradient NdFeB magnets. The effects of oscillating fields were frequency-dependent, with 4 Hz yielding optimal results. Transfection efficacies obtained using magnetofection methods were highly competitive with or better than current widely used nonviral transfection methods (e.g., electroporation and lipofection) with the additional critical advantage of high cell viability. No adverse effects were found on the cells' ability to divide or give rise to their daughter cells, the oligodendrocytes-key properties that underpin their regeneration-promoting effects. The transplantation potential of transfected cells was tested in three-dimensional tissue engineering models utilizing brain slices as the host tissue; modified transplanted cells were found to migrate, divide, give rise to daughter cells, and integrate within host tissue, further evidencing the safety of the protocols used. Our findings strongly support the concept that magnetic nanoparticle vectors in conjunction with state-of-the-art magnetofection strategies provide a technically simple and effective alternative to current methods for gene transfer to oligodendrocyte precursor cells.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Tissue Engineering and Regenerative Medicine · Nerve injury and regeneration

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Cellular and Neural Engineering Group, Institute for Science and Technology in Medicine, Keele University, Keele, Staffordshire, ST5 5BG, United Kingdom

MRC Centre for Stem Cell Biology and Regenerative Medicine, and Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, United Kingdom

References (71)

Show source-provided references
1. Ben-Hur T. · Curr. Drug Targets · 2005 · 6 · 310.2174/1389450053345000 ↗
2. Kulbatski I. · Prog. Histochem. Cytochem. · 2008 · 43 · 12310.1016/j.proghi.2008.04.001 ↗
3. Moreno-Flores M. T. · Recent Pat. CNS Drug Discovery · 2006 · 1 · 5510.2174/157488906775245264 ↗
4. Ruff R. L. · Ann. N.Y. Acad. Sci. · 2008 · 1142 · 110.1196/annals.1444.004 ↗
5. Willerth S. M. · Adv. Drug Delivery Rev. · 2008 · 60 · 26310.1016/j.addr.2007.08.028 ↗
6. Franklin R. J. M. · Nat. Rev. Neurosci. · 2008 · 9 · 83910.1038/nrn2480 ↗
7. Rodriguez M. A · Brain · 2003 · 126 · 75110.1093/brain/awg070 ↗
8. Stangel M. · J. Neurol. · 2008 · 255 · 7710.1007/s00415-008-6014-x ↗
9. Keirstead H. S. · J. Neurosci. · 2005 · 25 · 469410.1523/JNEUROSCI.0311-05.2005 ↗
10. Buchet D. · Neurosci. Lett. · 2009 · 456 · 11210.1016/j.neulet.2008.09.086 ↗
11. Windrem M. S. · Nat. Med. · 2004 · 10 · 9310.1038/nm974 ↗
12. http://www.geron.com/GRNOPC1Trial/grnopc1-backgrounder.pdf(accessed May 20, 2011) .
13. Bambakidis N. C. · Spine J. · 2004 · 4 · 1610.1016/j.spinee.2003.07.004 ↗
14. Cao Q. · J. Neurosci. · 2005 · 25 · 694710.1523/JNEUROSCI.1065-05.2005 ↗
15. Cao Q. · J. Neurosci. · 2010 · 30 · 298910.1523/JNEUROSCI.3174-09.2010 ↗
16. Stangel M. · Curr. Neurol. Neurosci. Rep. · 2006 · 6 · 22910.1007/s11910-006-0010-2 ↗
17. Blakemore W. F. · J. Neurol. Sci. · 2008 · 265 · 110.1016/j.jns.2007.03.006 ↗
18. Magy L. · Exp. Neurol. · 2003 · 184 · 91210.1016/j.expneurol.2003.08.019 ↗
19. Rubio N. · Glia · 2004 · 47 · 7810.1002/glia.20035 ↗
20. Himes B. T. · J. Neurosci. Res. · 2001 · 65 · 54910.1002/jnr.1185 ↗
21. Holland E. C. · Proc. Natl. Acad. Sci. U. S. A. · 1998 · 95 · 121810.1073/pnas.95.3.1218 ↗
22. Martinez-Serrano A. · J. Neurosci. · 1995 · 15 · 566810.1523/JNEUROSCI.15-08-05668.1995 ↗
23. Maurer M. H. · Int. J. Biol. Sci. · 2007 · 4 · 1
24. McTigue D. M. · J. Neurosci. · 1998 · 18 · 535410.1523/JNEUROSCI.18-14-05354.1998 ↗
25. Blits B. · J. Neurotrauma · 2006 · 23 · 50810.1089/neu.2006.23.508 ↗
26. Jiang S. · J. Biol. Chem. · 2007 · 282 · 1231910.1074/jbc.M701019200 ↗
27. Franklin R. · Gene Ther. · 1999 · 6 · 136010.1038/sj.gt.3300971 ↗
28. Hermens W. T. · Prog. Neurobiol. · 1998 · 55 · 39910.1016/S0301-0082(98)00007-0 ↗
29. Jeffery N. D. · J. Tissue Eng. Regen. Med. · 2009 · 3 · 15310.1002/term.139 ↗
30. Krueger W. H. · Neurochem. Res. · 1998 · 23 · 42110.1023/A:1022426021173 ↗
31. Pichon C. · Curr. Opin. Biotechnol. · 2010 · 21 · 64010.1016/j.copbio.2010.07.003 ↗
32. Ryan D. A. · Expert Opin. Biol. Ther. · 2007 · 7 · 30510.1517/14712598.7.3.305 ↗
33. Guo Z. · J. Neurosci. Res. · 1996 · 43 · 3210.1002/jnr.490430104 ↗
34. Berry C. C. · J. Phys. D: Appl. Phys. · 2009 · 42 · 110.1088/0022-3727/42/22/224003 ↗
35. Dobson J. · Nanomedicine (London) · 2006 · 1 · 3110.2217/17435889.1.1.31 ↗
36. de la Fuente J. M. · Langmuir · 2006 · 22 · 328610.1021/la053029v ↗
37. Kempe M · Biomaterials · 2010 · 31 · 949910.1016/j.biomaterials.2010.07.107 ↗
38. McBain S. C. · Int. J. Nanomed. · 2008 · 3 · 169
39. Tandon P. · Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. · 2011 · 3 · 510.1002/wnan.117 ↗
40. Yiu H. H. · J. Biomed. Mater. Res. A · 2010 · 92 · 38610.1002/jbm.a.32363 ↗
41. Hanessian S. · Bioorg. Med. Chem. · 2008 · 16 · 292110.1016/j.bmc.2007.12.051 ↗
42. Dunning M. D. · J. Neurosci. · 2004 · 24 · 979910.1523/JNEUROSCI.3126-04.2004 ↗
43. Bulte J. W. M. · Proc. Natl. Acad. Sci. U. S. A. · 1999 · 96 · 1525610.1073/pnas.96.26.15256 ↗
44. Laurent N. · Ther. Delivery · 2011 · 2 · 47110.4155/tde.11.12 ↗
45. Plank C. · Biol. Chem. · 2003 · 384 · 73710.1515/BC.2003.082 ↗
46. Sapet C. · Biotechniques · 2011 · 50 · 18710.2144/000113628 ↗
47. Scherer F. · Gene Ther. · 2002 · 9 · 10210.1038/sj.gt.3301624 ↗
48. Huth S. · J. Gene Med. · 2004 · 6 · 92310.1002/jgm.577 ↗
49. Khalil I. A. · Pharmacol. Rev. · 2006 · 58 · 3210.1124/pr.58.1.8 ↗
50. Pickard M. R. · Tissue Eng. Part C · 2010 · 17 · 8910.1089/ten.tec.2010.0170 ↗
51. Plank C. · J. Liposome Res. · 2003 · 13 · 2910.1081/LPR-120017486 ↗
52. Smith C. A. · Biomaterials · 2010 · 31 · 439210.1016/j.biomaterials.2010.01.096 ↗
53. Pickard M. R. · Nanomedicine (London) · 2010 · 5 · 21710.2217/nnm.09.109 ↗
54. Pickard, M. R.; Chari, D. M.Magnetic Nanoparticle Applications for Neural Stem Cell Transplantation Therapies.Programme of the Fourth Annual Scientific Conference of the UK National Stem Cell Network, University of York, March 30–April 1, 2011. Abstract: Poster number 83.
55. Pickard M. R. · Biomaterials · 2011 · 32 · 227410.1016/j.biomaterials.2010.12.007 ↗
56. Lubetzki C. · Ann. N.Y. Acad. Sci. · 1990 · 605 · 6610.1111/j.1749-6632.1990.tb42381.x ↗
57. http://www.lonzabio.com/fileadmin/groups/marketing/Downloads/Protocols/Generated/Optimized_Protocol_99.pdf(accessed May 20, 2011) .
58. Hermens W. T. J. M. C. · J. Neurosci. Methods · 1997 · 71 · 8510.1016/S0165-0270(96)00129-X ↗
59. McBain S. C. · Nanotechnology · 2008 · 19 · 40510210.1088/0957-4484/19/40/405102 ↗
60. Baumann N. · Physiol. Rev. · 2001 · 81 · 87110.1152/physrev.2001.81.2.871 ↗
61. Chari D. M. · Int. Rev. Neurobiol. · 2007 · 79 · 58910.1016/S0074-7742(07)79026-8 ↗
62. de Castro F. · Brain Res. Rev. · 2005 · 49 · 22710.1016/j.brainresrev.2004.12.034 ↗
63. Baron W. · Mol. Cell. Neurosci. · 2000 · 15 · 31410.1006/mcne.1999.0827 ↗
64. Gahwiler B. H. · Trends Neurosci. · 1997 · 20 · 47110.1016/S0166-2236(97)01122-3 ↗
65. Sundstrom L. · Drug Discovery Today · 2005 · 10 · 99310.1016/S1359-6446(05)03502-6 ↗
66. Xiang Z. · Exp. Neurol. · 2009 · 215 · 4110.1016/j.expneurol.2008.09.010 ↗
67. Birgbauer E. · J. Neurosci. Res. · 2004 · 78 · 15710.1002/jnr.20248 ↗
68. McKenzie I. A. · J. Neurosci. · 2006 · 26 · 665110.1523/JNEUROSCI.1007-06.2006 ↗
69. Forget C. · Eur. J. Neurosci. · 2006 · 23 · 60810.1111/j.1460-9568.2006.04570.x ↗
70. Gomez-Pinilla F. · J. Neurosci. · 1995 · 15 · 202110.1523/JNEUROSCI.15-03-02021.1995 ↗
71. McCarthy K. D. · J. Cell Biol. · 1980 · 85 · 89010.1083/jcb.85.3.890 ↗